Experts discuss US consumer confidence data, Carnival earnings, and the impact of AI on finance at Bloomberg Invest Event. Insights on blending quant strategies with fundamental analysis, managing risk, and tech trends in the financial sector.

Researchers discuss the potential of CDK9 inhibitors in treating hematological malignancies by targeting cancer-promoting genes like MYC and MCL1. Preclinical studies show promising results, with enitociclib demonstrating clinical activity in high-grade B lymphoma patients. CDK9 inhibitors may offer synergistic effects when combined with other drugs in the treatment of these malignancies.